Want to see OMDA full AI Analyst Report?

Omada Health, Inc. (OMDA) Stock Forecast & Price Target

189 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

OMDA Analyst Ratings

Strong Buy

10 Buy

0 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Omada

Health, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

OMDA Stock 12 Month Forecast

Average Price Target

$27.70

▲(15.71% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Omada Health, Inc. in the last 3 months. The average price target is $27.70 with a high forecast of $35.00 and a low forecast of $24.00. The average price target represents a 15.71% change from the last price of $23.94.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","36":"$36","17.25":"$17.25","23.5":"$23.5","29.75":"$29.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$24.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,17.25,23.5,29.75,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.84,21.006153846153847,22.17230769230769,23.338461538461537,24.504615384615384,25.67076923076923,26.836923076923078,28.00307692307692,29.16923076923077,30.335384615384616,31.50153846153846,32.667692307692306,33.83384615384615,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.84,20.444615384615386,21.049230769230768,21.653846153846153,22.25846153846154,22.863076923076925,23.467692307692307,24.072307692307692,24.676923076923075,25.28153846153846,25.886153846153846,26.49076923076923,27.095384615384614,{"y":27.7,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.84,20.16,20.48,20.8,21.12,21.44,21.759999999999998,22.08,22.4,22.72,23.04,23.36,23.68,{"y":24,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.57,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.73,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.78,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.86,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.9,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.61,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.29,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.38,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.62,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.84,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$35.00

Average Price Target$27.70

Lowest Price Target$24.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lisa Gill

J.P. Morgan

$26→$30

Buy

25.31%

Upside

Reiterated

08/14/26

Analysts Conflicted on These NA Names: Bending Spoons (NASDAQ: BSP), Alliance Laundry Holdings, Inc. (NYSE: ALH) and Omada Health, Inc. (NASDAQ: OMDA)

Richard Close

Canaccord Genuity

$28

Buy

16.96%

Upside

Reiterated

08/11/26

Omada Health, Inc. (OMDA) Receives a Buy from Canaccord Genuity

David Larsen

BTIG

$30→$35

Buy

46.20%

Upside

Assigned

08/10/26

BTIG’s David Larsen Boosts Omada Health Price Target to $35 on Strong Execution, GLP-1 Tailwinds, and Membership Growth

Saket Kalia

Barclays

$25

Buy

4.43%

Upside

Reiterated

08/07/26

Analysts' Opinions Are Mixed on These NA Stocks: Omada Health, Inc. (NASDAQ: OMDA) and FrontView REIT, Inc. (NYSE: FVR)

Craig Hettenbach

Morgan Stanley

$30

Buy

25.31%

Upside

Reiterated

08/07/26

Analysts Offer Insights on NA Companies: Emerson Electric Company (NYSE: EMR), Omada Health, Inc. (NASDAQ: OMDA) and Guardian Pharmacy Services, Inc. Class A (NYSE: GRDN)

Elizabeth Anderson CFA

Evercore ISI

$25

Buy

4.43%

Upside

Reiterated

08/07/26

Evercore ISI Sticks to Their Buy Rating for Omada Health, Inc. (OMDA)

Ryan MacDonald

Needham

$28

Buy

16.96%

Upside

Reiterated

08/07/26

Analysts Are Bullish on Top NA Stocks: Exzeo Group, Inc. (XZO), Omada Health, Inc. (OMDA)

Sean Dodge

BMO Capital

$20→$24

Buy

0.25%

Upside

Assigned

08/06/26

Omada Health price target raised to $24 from $18 at BMO CapitalOmada Health price target raised to $24 from $18 at BMO Capital

Constantine Davides

Citizens JMP

$21→$27

Buy

12.78%

Upside

Reiterated

07/20/26

Omada Health price target raised to $27 from $21 at CitizensOmada Health price target raised to $27 from $21 at Citizens

David Roman

Goldman Sachs

$26→$25

Buy

4.43%

Upside

Reiterated

06/10/26

David Roman Reaffirms Buy on Omada Health as Strong Q1, Higher 2026 Guidance and Margin Upside Signal Underappreciated Growth

Stan Berenshteyn

Wells Fargo

$17→$18

Hold

-24.81%

Downside

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Owlet (NYSE: OWLT), Omada Health, Inc. (NASDAQ: OMDA) and AbSci (NASDAQ: ABSI)

Vikram Kesavabhotla

Robert W. Baird

$24

Hold

0.25%

Upside

Initiated

09/04/25

Omada Health initiated with a Neutral at BairdOmada Health initiated with a Neutral at Baird

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lisa Gill

J.P. Morgan

$26→$30

Buy

25.31%

Upside

Reiterated

08/14/26

Analysts Conflicted on These NA Names: Bending Spoons (NASDAQ: BSP), Alliance Laundry Holdings, Inc. (NYSE: ALH) and Omada Health, Inc. (NASDAQ: OMDA)

Richard Close

Canaccord Genuity

$28

Buy

16.96%

Upside

Reiterated

08/11/26

Omada Health, Inc. (OMDA) Receives a Buy from Canaccord Genuity

David Larsen

BTIG

$30→$35

Buy

46.20%

Upside

Assigned

08/10/26

BTIG’s David Larsen Boosts Omada Health Price Target to $35 on Strong Execution, GLP-1 Tailwinds, and Membership Growth

Saket Kalia

Barclays

$25

Buy

4.43%

Upside

Reiterated

08/07/26

Analysts' Opinions Are Mixed on These NA Stocks: Omada Health, Inc. (NASDAQ: OMDA) and FrontView REIT, Inc. (NYSE: FVR)

Craig Hettenbach

Morgan Stanley

$30

Buy

25.31%

Upside

Reiterated

08/07/26

Analysts Offer Insights on NA Companies: Emerson Electric Company (NYSE: EMR), Omada Health, Inc. (NASDAQ: OMDA) and Guardian Pharmacy Services, Inc. Class A (NYSE: GRDN)

Elizabeth Anderson CFA

Evercore ISI

$25

Buy

4.43%

Upside

Reiterated

08/07/26

Evercore ISI Sticks to Their Buy Rating for Omada Health, Inc. (OMDA)

Ryan MacDonald

Needham

$28

Buy

16.96%

Upside

Reiterated

08/07/26

Analysts Are Bullish on Top NA Stocks: Exzeo Group, Inc. (XZO), Omada Health, Inc. (OMDA)

Sean Dodge

BMO Capital

$20→$24

Buy

0.25%

Upside

Assigned

08/06/26

Omada Health price target raised to $24 from $18 at BMO CapitalOmada Health price target raised to $24 from $18 at BMO Capital

Constantine Davides

Citizens JMP

$21→$27

Buy

12.78%

Upside

Reiterated

07/20/26

Omada Health price target raised to $27 from $21 at CitizensOmada Health price target raised to $27 from $21 at Citizens

David Roman

Goldman Sachs

$26→$25

Buy

4.43%

Upside

Reiterated

06/10/26

David Roman Reaffirms Buy on Omada Health as Strong Q1, Higher 2026 Guidance and Margin Upside Signal Underappreciated Growth

Stan Berenshteyn

Wells Fargo

$17→$18

Hold

-24.81%

Downside

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Owlet (NYSE: OWLT), Omada Health, Inc. (NASDAQ: OMDA) and AbSci (NASDAQ: ABSI)

Vikram Kesavabhotla

Robert W. Baird

$24

Hold

0.25%

Upside

Initiated

09/04/25

Omada Health initiated with a Neutral at BairdOmada Health initiated with a Neutral at Baird

Stocks with the Highest Top Analyst Consensus in the General Sector

STDNStandard Nuclear

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Omada Health, Inc.

3 Months

David RomanGoldman Sachs

Success Rate

5/6 ratings generated profit

Average Return

+34.97%

Copying David Roman's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +34.97% per trade.

1 Year

David RomanGoldman Sachs

Success Rate

6/6 ratings generated profit

Average Return

+54.83%

Copying David Roman's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +54.83% per trade.

2 Years

David RomanGoldman Sachs

Success Rate

6/6 ratings generated profit

Average Return

+56.43%

Copying David Roman's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +56.43% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OMDA Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, OMDA has received 17 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OMDA average Analyst price target in the past 3 months is 27.70.

Each month's total comprises the sum of three months' worth of ratings.

OMDA Financial Forecast

OMDA Earnings Forecast

Next quarter’s earnings estimate for OMDA is $0.08 with a range of -$0.03 to $0.12. The previous quarter’s EPS was $0.18. OMDA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year OMDA has Performed in-line its overall industry.

OMDA Sales Forecast

Next quarter’s sales forecast for OMDA is $85.47M with a range of $83.90M to $86.40M. The previous quarter’s sales results were $87.83M. OMDA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year OMDA has Performed in-line its overall industry.

OMDA Stock Forecast FAQ

What is OMDA’s average 12-month price target, according to analysts?

Based on analyst ratings, Omada Health, Inc.’s 12-month average price target is 27.70.

What is OMDA’s upside potential, based on the analysts’ average price target?

Omada Health, Inc. has 15.71% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is OMDA a Buy, Sell or Hold?

Omada Health, Inc. has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.

What is Omada Health, Inc.’s price target?

The average price target for Omada Health, Inc. is 27.70. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $24.00. The average price target represents 15.71% Increase from the current price of $23.94.

What do analysts say about Omada Health, Inc.?

Omada Health, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of OMDA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Omada Health, Inc. (OMDA) Stock Forecast & Price Target

OMDA Analyst Ratings

OMDA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Omada Health, Inc.

OMDA Analyst Recommendation Trends

OMDA Financial Forecast

OMDA Earnings Forecast

OMDA Sales Forecast

OMDA Stock Forecast FAQ

Detailed List of Analyst Forecasts